| Lymphocyte-to-C-reactive protein ratio may serve as an effective biomarker to determine COVID-19 disease severity T Bal, S Dogan, M Cabalak, E Dirican Turkish Journal of Biochemistry 1 (ahead-of-print), 2020 | 27 | 2020 |
| Brucellar epididymo-orchitis: a retrospective study of 25 cases HT Gozdas, T Bal The Aging Male, 2019 | 18 | 2019 |
| Beclin-1, an autophagy-related protein, is associated with the disease severity of COVID-19 HM Okuyan, S Dogan, T Bal, M Çabalak Life Sciences 278, 119596, 2021 | 17 | 2021 |
| Oxidative stress index can be a new marker related to disease severity in COVID-19 S Doğan, T Bal, M Çabalak, N Dikmen, H Yaqoobi, O Ozcan Turkish Journal of Biochemistry 46 (4), 349-357, 2021 | 15 | 2021 |
| Chest CT in COVID-19 pneumonia: correlations of imaging findings in clinically suspected but repeatedly RT-PCR test-negative patients I Korkmaz, N Dikmen, FO Keleş, T Bal Egyptian Journal of Radiology and Nuclear Medicine 52, 1-9, 2021 | 14 | 2021 |
| COVID-19 disease severity to predict persistent symptoms: a systematic review and meta-analysis E Dirican, T Bal Primary Health Care Research & Development 23, e69, 2022 | 13 | 2022 |
| The impact of hepatitis C viremia status on lung functions in chronic hepatitis c patients T Bal, Y Onlen, C Babayigit, Y Yumer, SI Sahin African Health Sciences 19 (2), 1988-1992, 2019 | 6 | 2019 |
| The prevalence of occult hepatitis B in chronic hepatitis C patients treated with interferon-based antiviral therapy T Bal, Y Onlen Arab journal of gastroenterology 19 (1), 33-36, 2018 | 6 | 2018 |
| Serum periostin levels in COVID‐19: Is it useful as a new biomarker? M Cabalak, S Doğan, T Bal, N Dikmen International Journal of Clinical Practice 75 (11), e14728, 2021 | 4 | 2021 |
| Incidence and predictors of direct-acting antiviral treatment failure in Turkish patients with chronic hepatitis C genotype 1b infection M Cabalak, T Bal, Y Onlen, M Demir Tropical Doctor 50 (2), 141-146, 2020 | 3 | 2020 |
| Sofosbuvir and Ribavirin in Turkish non-cirrhotic chronic hepatitis C patients infected with genotype 2 or 3 T Bal, M Cabalak | 3 | 2020 |
| Hıv pozitif olgularda viral hepatit ve sifiliz koinfeksiyonu seroprevalansının irdelenmesi M Çabalak, T Bal Bilimsel Tıp Yayınevi, Tuba Yıldırım, 2020 | 2 | 2020 |
| An Acute Brucellosis Case Presented with Pancytopenia and Hepatitis H Bilek, Ü Alanbayı, T Bal Dicle Tıp Dergisi 45 (1), 20-25, 2018 | 2 | 2018 |
| Relationship of thrombospondin-1 and thrombospondin-2 with hematological, biochemical and inflammatory markers in COVID-19 patients S Dogan, HM Okuyan, T Bal, M Çabalak, MA Begen Turkish Journal of Biochemistry 48 (4), 368-375, 2023 | 1 | 2023 |
| Efficacy and safety of direct-acting antivirals in elderly patients with chronic hepatitis C: A nationwide real-life, observational, multicenter study from Turkey Y Önlen, T Bal, M Çabalak, NÇ Öztoprak, ND Sarı, B Kurtaran, E Şenateş, ... The Turkish Journal of Gastroenterology 33 (10), 862, 2022 | 1 | 2022 |
| Relationship between COVID-19 infection and ABO and Rh blood group systems TD ÇAKIRCA, BAL Tayibe Cukurova Medical Journal 47 (4), 1485-1491, 2022 | 1 | 2022 |
| Electrocardiographic findings and cardiac safety of hydroxychloroquine+ azithromycin in hospitalized patients with COVID-19 O Akkus, T Bal, H Yagoobi, O Bekler, G Akkus, M Çabalak Cukurova Med J 46 (2), 691-698, 2021 | 1 | 2021 |
| EFFECTIVENESS OF ORAL DIRECT ACTING ANTIVIRALS IN ELDERLY CHRONIC HEPATITIS C PATIENTS: REAL-WORLD DATA. M Cabalak, T Bal Turkish Journal of Geriatrics/Türk Geriatri Dergisi 23 (4), 2020 | 1 | 2020 |
| Genotype distribution of hepatitis C virus in Hatay province of Turkey M Çabalak, T Bal, M Demir, S Ocak, Y Önlen Viral Hepatit Dergisis 26 (2), 56, 2020 | 1 | 2020 |
| Effect of hepatitis C infection and its clearance on the frequency of coronary artery disease in diabetics T Bal, C Kurtdere, Y Önlen, M Çabalak Galenos Yayınevi, 2020 | 1 | 2020 |
